Attributes | Values |
---|
rdf:type
| |
Description
| - Systemic literary review of published studies informing the EULAR recommendations for the ma-nagement and therapy of rheumatoid arthritis with biological disease-modifying antirheumatic drugs published in last 10 years.
- Systemic literary review of published studies informing the EULAR recommendations for the ma-nagement and therapy of rheumatoid arthritis with biological disease-modifying antirheumatic drugs published in last 10 years. (en)
|
Title
| - Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
- Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA (en)
|
skos:prefLabel
| - Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
- Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA (en)
|
skos:notation
| - RIV/00023728:_____/10:#0000073!RIV11-MZ0-00023728
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00023728:_____/10:#0000073
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - antitumor-necrosis-factor; placebo-controlled trial; interleukin-1 receptor antagonist; receiving concomitant methotrexate; adalimumab plus methotrexate; randomized controlled-trial; alpha monoclonal-antibody; interstitial lung-disease; phase-iii trial; double-blind (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - ANNALS OF THE RHEUMATIC DISEASES
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Pavelka, Karel
- Emery, Paul
- Buch, Maya
- Smolen, Josef S.
- Hensor, E.M.A.
- Landewe, Robert
- Nam, Jackie
- Valesini, Guido
- Vollenhoven, Ronald, van
- Winthrop, Kevin L.
- Worthy, G.
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |
is http://linked.open...avai/riv/vysledek
of | |